chevron_leftBack
As of 13 June 2026, PMV Pharmaceuticals, Inc. has a market cap of $74.39M USD, ranking #27685 globally and #4186 in the United States.
It ranks #2496 in the Healthcare sector, and #479 in the Biotechnology industry.
Key Stats
Market Cap
$74.39MUSD
Enterprise Value
-$37.98MUSD
EBITDA (TTM)
-$86.07MUSD
Net Income (TTM)
-$77.74MUSD
PB Ratio
0.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
David Mack
open_in_new
Employees
54
Founded
2013
IPO
25 Sep 2020
Website
pmvpharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.8% | -4.8% | 6.1% | 14% | -5.4% | 39% |
News
Loading...
PMVP Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PMVP
PMV Pharmaceuticals Inc Ordinary Shares
ISIN: US69353Y1038
Shares Out.:
Shares Outstanding:
53.332M1
Shares Float:
48.896M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
1.40 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
245K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
215K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
37K%
|
-
|
|
NYSE: IQV
|
$26.3B
35K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
34K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
24K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$47.84B
64K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.84B
60K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.36B
57K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.3B
57K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$28.11B
38K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
34K%
|
-
|
chevron_leftBack